Pediatric Asplenia Workup

  • Author: Joseph C Turbyville, MD; Chief Editor: Harumi Jyonouchi, MD   more...
 
Updated: Apr 3, 2012
 

Laboratory Studies

  • Often the first clues to functional asplenia in an asymptomatic patient are abnormalities in the peripheral blood smear.
    • The initial evaluation should begin with a review to identify HJ bodies (see the image below).Peripheral blood smear shows Howell-Jolly (HJ) bodPeripheral blood smear shows Howell-Jolly (HJ) bodies in RBCs.
    • The nuclear remnants are small, round, densely stained inclusions in RBCs. They can be seen as a normal variant in the newborn period and are occasionally seen in leukemia, steatorrhea, and a variety of anemias (megaloblastic anemia, dyserythropoietic anemia, thalassemia).
    • The presence of HJ bodies in the peripheral smear of an individual older than 7 days should suggest splenic dysfunction.
    • Other red cell abnormalities include an increased presence of target cells, Heinz bodies, Pappenheimer bodies (small basophilic inclusions that contain nonheme iron), reticulocytes, and spherocytes.
    • In addition, thrombocytosis and leukocytosis are observed because the spleen functions as a reservoir for these blood cells.
  • Another helpful means of screening the splenic function is by determining the pit (autophagic vacuoles) count (ie, counting the number of pocked erythrocytes).
    • Normally, less than 2% of red cells have these pocks or pits. A pocked erythrocyte count of more than 3.5% suggests functional hyposplenia, and a count of more than 12% is indicative of asplenia.
    • This technique involves the use of special equipment (Nomarski optics) that is not always readily accessible.
  • An assessment of the argyrophilic granules in the peripheral smear may be a helpful and easy method to detect splenic dysfunction, but the procedure needs further evaluation.
  • HJ body quantitation by flow cytometry has also been described as a way to assay for splenic function but is not currently available, except in specialized laboratories.
Next

Imaging Studies

  • Various imaging modalities may be helpful in defining splenic anomalies.
  • Certain associated anomalies, especially cardiac and visceral changes, often lead to further evaluation of the spleen.
  • Abdominal ultrasonography can be performed to document the presence of the spleen and its size, and newer ultrasonography techniques with color Doppler ultrasonography have shown promise in assessing splenic function. A small spleen with absent parenchymal vascularization on color Doppler ultrasonography has been associated with functional asplenia, but this should be confirmed with further imaging before declaring a patient functionally asplenic.
  • The absence of the spleen is best confirmed with a technetium-99m radionuclide scan. This agent is taken up by the reticuloendothelial cells and enables better assessment of splenic function. Similarly, as a result of functional asplenia, patients with sickle cell disease who still have normal-sized and even enlarged spleens demonstrate absent or decreased splenic uptake of technetium-99m sulfur colloid.
  • Absence of the intrahepatic segment of the inferior vena cava should trigger careful evaluation of abdominal masses, which could represent splenules. These masses can be confused with multiple metastatic lesions in patients, especially adults, in whom asplenia or polysplenia is undiagnosed.
  • MRI or CT scanning of the abdomen may also reveal absence or hypoplasia of the spleen. These studies have no place in the routine workup of isolated asplenia or hyposplenia but may be useful if they are obtained for other accompanying indications, such as visceral heterotaxy. Newer MRI techniques have expanded the role of MRI in the detection and characterization of splenic diseases.[6]
  • Computerized models are available to determine the splenic volume, but this approach is mainly used to judge the increased size (eg, tumors, infiltrations) of organs. With more experience, computerized models may provide important information about conditions that decrease the size and volume of the spleen.
  • If the spleen is not visualized with radiographic imaging and if no hematologic data support the diagnosis of asplenia, the extremely rare condition of wandering spleen may be considered. In this condition, a functional spleen is present; however, because of its long pedicle, it may be in an abnormal location, such as the pelvis.
Previous
Next

Histologic Findings

  • A hypoplastic spleen may exhibit a hyperemic red pulp with underdevelopment of the white pulp and a paucity of lymphoid follicles.Peripheral blood smear shows Howell-Jolly (HJ) bodPeripheral blood smear shows Howell-Jolly (HJ) bodies in RBCs.
  • When hyposplenia is secondary to an underlying hemoglobinopathy such as sickle cell disease, specific histologic features may be observed because of infarction (see History).
Previous
Proceed to Treatment & Management
 
 
Contributor Information and Disclosures
Author

Joseph C Turbyville, MD  Chief, Department of Allergy and Immunology, Ireland Army Community Hospital, Fort Knox, KY

Joseph C Turbyville, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, and American College of Allergy, Asthma and Immunology

Disclosure: Nothing to disclose.

Coauthor(s)

Cecilia P Mikita, MD, MPH  Associate Program Director, Allergy-Immunology Fellowship, Associate Professor of Pediatrics and Medicine, Uniformed Services University of the Health Sciences; Staff Allergist/Immunologist, Walter Reed National Military Medical Center

Cecilia P Mikita, MD, MPH is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American College of Allergy, Asthma and Immunology, and Clinical Immunology Society

Disclosure: Nothing to disclose.

Mudra Kumar, MD, MBBS, MRCP  Associate Professor, Department of Pediatrics, University of South Florida College of Medicine

Mudra Kumar, MD, MBBS, MRCP is a member of the following medical societies: American Academy of Pediatrics and American Society of Hematology

Disclosure: Nothing to disclose.

Specialty Editor Board

Ann O'Neill Shigeoka, MD †  Former Clinical Associate Professor, Department of Pediatrics, Division of Immunology-Rheumatology, University of Utah School of Medicine

Ann O'Neill Shigeoka, MD † is a member of the following medical societies: American Federation for Medical Research, Clinical Immunology Society, Pediatric Infectious Diseases Society, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

John Wilson Georgitis, MD  Consulting Staff, Lafayette Allergy Services

John Wilson Georgitis, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American Association for the Advancement of Science, American College of Chest Physicians, American Lung Association, American Medical Writers Association, and American Thoracic Society

Disclosure: Nothing to disclose.

David Pallares, MD  Clinical Assistant Professor, Department of Pediatrics, Division of Allergy and Immunology, University of Louisville School of Medicine

David Pallares, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology

Disclosure: Nothing to disclose.

Chief Editor

Harumi Jyonouchi, MD  Associate Professor, Division of Pulmonary, Allergy/Immunology, and Infectious Diseases, Department of Pediatrics, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Harumi Jyonouchi, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American Association of Immunologists, American Medical Association, Clinical Immunology Society, New York Academy of Sciences, Society for Experimental Biology and Medicine, Society for Mucosal Immunology, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Additional Contributors

Thanks to Oswaldo Castro, MD, for his assistance in reviewing this manuscript and providing expertise with regards to management of patients with sickle cell disease and asplenia.

References

  1. Fremont RD, Rice TW. Splenosis: a review. South Med J. Jun 2007;100(6):589-93. [Medline].

  2. Leahy RT, Philip RK, Gibbons RJ, et al. Asplenia in ATR-X Syndrome: a second report. Am J Med Genet A. 2005;15;139 (1):37-9. [Medline].

  3. Pollak U, Bar-Sever Z, Hoffer V, Marcus N, Scheuerman O, Garty BZ. Asplenia and functional hyposplenism in autoimmune polyglandular syndrome type 1. Eur J Pediatr. Feb 2009;168(2):233-5. [Medline].

  4. Casey B, Devoto M, Jones KL, Ballabio A. Mapping a gene for familial situs abnormalities to human chromosome Xq24-q27.1. Nat Genet. Dec 1993;5(4):403-7. [Medline].

  5. US Preventive Services Task Force. Screening for sickle cell disease in newborns: recommendation statement. Am Fam Physician. May 1 2008;77(9):1300-2. [Medline].

  6. Committee on Infectious Diseases American Academy of Pediatrics. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th Ed. 2006.

  7. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. MMWR Morb Mortal Wkly Rep. Sep 25 2009;58(37):1042-3. [Medline].

  8. Elsayes KM, Narra VR, Mukundan G, et al. MR imaging of the spleen: spectrum of abnormalities. Radiographics. 2005;Jul-Aug;25(4):967-82. [Medline]. [Full Text].

  9. Garson A, Bricker JT, McNamara DG. The Science and Practice of Pediatric Cardiology. Vol 3. 1990:1288-97.

  10. Gill DG, Kara M, Moore L. Archives of diseases in childhood. Vol 66. 1991:1366.

  11. Gorg C, Eickhorn M, Zugmaier G. The small spleen: sonographic patterns of functional hyposplenia or asplenia. J Clin Ultrasound. 2003;Mar-Apr;31(3):152-5. [Medline].

  12. Harrod VL, Howard TA, Zimmerman SA, Dertinger SD, Ware RE. Quantitative analysis of Howell-Jolly bodies in children with sickle cell disease. Exp Hematol. Feb 2007;35(2):179-83. [Medline].

  13. Katcher AL. Familial asplenia, other malformations, and sudden death. Pediatrics. 1980;65(3):633-635. [Medline].

  14. Kevy SV, Tefft M, Vawier GF, Rosen FS. Hereditary splenic hypoplasia. Pediatrics. Nov 1968;42(5):752-7. [Medline].

  15. Lane PA, O'Connell JL, Lear JL, et al. Functional asplenia in hemoglobin SC disease. Blood. Apr 15 1995;85(8):2238-44. [Medline].

  16. Lin XZ, Chang TM, Tsai HM, et al. Liver, spleen and tumor volume measured by personal computer. Hepatogastroenterology. Mar-Apr 1999;46(26):838-42. [Medline].

  17. Lindor NM, Smithson WA, Ahumada CA, et al. Asplenia in two father-son pairs. Am J Med Genet. Mar 13 1995;56(1):10-1. [Medline].

  18. Long WA. Ivemark syndrome (cardiosplenic or heterotaxy syndrome). In: Fetal and Neonatal Cardiology. 1990:616-19.

  19. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. Aug 2005;5(8):606-16. [Medline].

  20. Melles DC, de Marie S. Prevention of infections in hyposplenic and asplenic patients: an update. Neth J Med. Feb 2004;62(2):45-52. [Medline].

  21. Moller JH, Neal WA. Congenital cardiac anomalies. In: Fetal, Neonatal, and Infant Cardiac Disease. 1990:767-71.

  22. Morgan MS. Prophylaxis should be considered even for trivial animal bites. BMJ. May 10 1997;314(7091):1413. [Medline].

  23. Pearson HA. The spleen and disturbances of splenic function. Hematology. 1993;2:1058-9.

  24. Price VE, Blanchette VS, Ford-Jones EL. The prevention and management of infections in children with asplenia or hyposplenia. Infect Dis Clin North Am. Sep 2007;21(3):697-710, viii-ix. [Medline].

  25. Price VE, Dutta S, Blanchette VS, et al. The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, Toronto. Pediatr Blood Cancer. 2006;May 1;46(5):597-603. [Medline].

  26. Rose V, Izukawa T, Moes CA. Syndromes of asplenia and polysplenia. A review of cardiac and non- cardiac malformations in 60 cases with special reference to diagnosis and prognosis. Br Heart J. Aug 1975;37(8):840-52. [Medline].

  27. Stiehm ER. Immunodeficiency disorders. In: Immunologic Disorders in Infants and Children. 4th ed. 1996:326-327.

  28. Tham KT, Teague MW, Howard CA, Chen SY. A simple splenic reticuloendothelial function test: counting erythrocytes with argyrophilic inclusions. Am J Clin Pathol. May 1996;105(5):548-52. [Medline].

  29. Tribioli C, Lufkin T. The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development. Dec 1999;126(24):5699-711. [Medline].

  30. Waldman JD, Rosenthal A, Smith AL, et al. Sepsis and congenital asplenia. J Pediatr. Apr 1977;90(4):555-9. [Medline].

  31. Wang JK, Hsieh KH. Immunologic study of the asplenia syndrome. Pediatr Infect Dis J. Nov 1991;10(11):819-22. [Medline].

 
Previous
Next
 
Peripheral blood smear shows Howell-Jolly (HJ) bodies in RBCs.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.